New

Gastritis Treatment Drugs Market

2021

Gastritis Treatment Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Acid-Blocking Medicines, Antibiotics, Antacids, Histamine Blockers, Others); Application (Hospitals, Clinics, Others)

| Report Code: TIPRE00021687 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Gastritis Treatment Drugs Market 2028 By Type, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Gastritis is an inflammation of the stomach lining. The patient could have either acute or chronic gastritis. If no symptoms of the disease are present, the disease can remain dormant. Upper abdominal pain, fatigue, and vomiting are experienced by approximately 80% of patients. There may be a link between gastritis, stomach cancers, ulcers, and stomach ulceration. The majority of helicobacter pylori-induced gastritis cases are linked to excessive use of nonsteroidal anti-inflammatory medications (NSAIDs). Tobacco, cocaine, and multiple sclerosis are all potential causes of vertigo. Gastritis patients are typically treated with H2 antagonists, antacids, or PPI medications. Acute gastritis can benefit from pain-drying medications such as viscous lignocaine. H. If m. pylori bacteria are present, this disease can be treated with a combination of clarithromycin and amoxicillin. As more people realise that gastritis can be treated, the demand for care will increase.

MARKET DYNAMICS

According to a study published in the National Center for Biotechnology Information, the number of global diseases is increasing. Helicobacter pylori, one of the major causes of gastritis, is responsible for more than half of all stomach infections worldwide. Concerns about the disease's spread are on the rise. The projected demand for disease care is expected to remain constant. Technological advancements have drastically altered the treatment of gastric distress. According to a study conducted by the National Center for Biotechnology Information, patients with mucous-lined atrophic gastritis have a higher risk of cancer (atrophic gastroesophageal reflux).

MARKET SCOPE

The "Gastritis Treatment Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gastritis Treatment Drugs Market with detailed market segmentation by type, application. The Gastritis Treatment Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Gastritis Treatment Drugs Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Gastritis Treatment Drugs Market is segmented on the basis of type, application. Based on type, the market is segmented as Acid-Blocking Medicines, Antibiotics, Antacids, Histamine Blockers, Others. Based on application, the market is segmented as Hospitals, Clinics, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Gastritis Treatment Drugs Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gastritis Treatment Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gastritis Treatment Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gastritis Treatment Drugs Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Gastritis Treatment Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gastritis Treatment Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Gastritis Treatment Drugs Market in the global market. Below mentioned is the list of few companies engaged in the Gastritis Treatment Drugs Market.

The report also includes the profiles of key players in Gastritis Treatment Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer
  •   AstraZeneca
  •   Novartis
  •   Cipla
  •   Abbott Laboratories
  •   Microbiotix
  •   Reddy's Laboratories
  •   Lupin Ltd
  •   Perrigo Pharmaceutical
  •   Sun Pharmaceutical Industries

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastritis Treatment Drugs Market - By Type
1.3.2 Gastritis Treatment Drugs Market - By Application
1.3.3 Gastritis Treatment Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTRITIS TREATMENT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTRITIS TREATMENT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GASTRITIS TREATMENT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTRITIS TREATMENT DRUGS - GLOBAL MARKET OVERVIEW
6.2. GASTRITIS TREATMENT DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTRITIS TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACID-BLOCKING MEDICINES
7.3.1. Overview
7.3.2. Acid-Blocking Medicines Market Forecast and Analysis
7.4. ANTIBIOTICS
7.4.1. Overview
7.4.2. Antibiotics Market Forecast and Analysis
7.5. ANTACIDS
7.5.1. Overview
7.5.2. Antacids Market Forecast and Analysis
7.6. HISTAMINE BLOCKERS
7.6.1. Overview
7.6.2. Histamine Blockers Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. GASTRITIS TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTRITIS TREATMENT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gastritis Treatment Drugs Market Overview
9.1.2 North America Gastritis Treatment Drugs Market Forecasts and Analysis
9.1.3 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gastritis Treatment Drugs Market
9.1.5.1.1 United States Gastritis Treatment Drugs Market by Type
9.1.5.1.2 United States Gastritis Treatment Drugs Market by Application
9.1.5.2 Canada Gastritis Treatment Drugs Market
9.1.5.2.1 Canada Gastritis Treatment Drugs Market by Type
9.1.5.2.2 Canada Gastritis Treatment Drugs Market by Application
9.1.5.3 Mexico Gastritis Treatment Drugs Market
9.1.5.3.1 Mexico Gastritis Treatment Drugs Market by Type
9.1.5.3.2 Mexico Gastritis Treatment Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Gastritis Treatment Drugs Market Overview
9.2.2 Europe Gastritis Treatment Drugs Market Forecasts and Analysis
9.2.3 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gastritis Treatment Drugs Market
9.2.5.1.1 Germany Gastritis Treatment Drugs Market by Type
9.2.5.1.2 Germany Gastritis Treatment Drugs Market by Application
9.2.5.2 France Gastritis Treatment Drugs Market
9.2.5.2.1 France Gastritis Treatment Drugs Market by Type
9.2.5.2.2 France Gastritis Treatment Drugs Market by Application
9.2.5.3 Italy Gastritis Treatment Drugs Market
9.2.5.3.1 Italy Gastritis Treatment Drugs Market by Type
9.2.5.3.2 Italy Gastritis Treatment Drugs Market by Application
9.2.5.4 Spain Gastritis Treatment Drugs Market
9.2.5.4.1 Spain Gastritis Treatment Drugs Market by Type
9.2.5.4.2 Spain Gastritis Treatment Drugs Market by Application
9.2.5.5 United Kingdom Gastritis Treatment Drugs Market
9.2.5.5.1 United Kingdom Gastritis Treatment Drugs Market by Type
9.2.5.5.2 United Kingdom Gastritis Treatment Drugs Market by Application
9.2.5.6 Rest of Europe Gastritis Treatment Drugs Market
9.2.5.6.1 Rest of Europe Gastritis Treatment Drugs Market by Type
9.2.5.6.2 Rest of Europe Gastritis Treatment Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gastritis Treatment Drugs Market Overview
9.3.2 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gastritis Treatment Drugs Market
9.3.5.1.1 Australia Gastritis Treatment Drugs Market by Type
9.3.5.1.2 Australia Gastritis Treatment Drugs Market by Application
9.3.5.2 China Gastritis Treatment Drugs Market
9.3.5.2.1 China Gastritis Treatment Drugs Market by Type
9.3.5.2.2 China Gastritis Treatment Drugs Market by Application
9.3.5.3 India Gastritis Treatment Drugs Market
9.3.5.3.1 India Gastritis Treatment Drugs Market by Type
9.3.5.3.2 India Gastritis Treatment Drugs Market by Application
9.3.5.4 Japan Gastritis Treatment Drugs Market
9.3.5.4.1 Japan Gastritis Treatment Drugs Market by Type
9.3.5.4.2 Japan Gastritis Treatment Drugs Market by Application
9.3.5.5 South Korea Gastritis Treatment Drugs Market
9.3.5.5.1 South Korea Gastritis Treatment Drugs Market by Type
9.3.5.5.2 South Korea Gastritis Treatment Drugs Market by Application
9.3.5.6 Rest of Asia-Pacific Gastritis Treatment Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Gastritis Treatment Drugs Market by Type
9.3.5.6.2 Rest of Asia-Pacific Gastritis Treatment Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gastritis Treatment Drugs Market Overview
9.4.2 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gastritis Treatment Drugs Market
9.4.5.1.1 South Africa Gastritis Treatment Drugs Market by Type
9.4.5.1.2 South Africa Gastritis Treatment Drugs Market by Application
9.4.5.2 Saudi Arabia Gastritis Treatment Drugs Market
9.4.5.2.1 Saudi Arabia Gastritis Treatment Drugs Market by Type
9.4.5.2.2 Saudi Arabia Gastritis Treatment Drugs Market by Application
9.4.5.3 U.A.E Gastritis Treatment Drugs Market
9.4.5.3.1 U.A.E Gastritis Treatment Drugs Market by Type
9.4.5.3.2 U.A.E Gastritis Treatment Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Gastritis Treatment Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Gastritis Treatment Drugs Market by Type
9.4.5.4.2 Rest of Middle East and Africa Gastritis Treatment Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gastritis Treatment Drugs Market Overview
9.5.2 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis
9.5.3 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gastritis Treatment Drugs Market
9.5.5.1.1 Brazil Gastritis Treatment Drugs Market by Type
9.5.5.1.2 Brazil Gastritis Treatment Drugs Market by Application
9.5.5.2 Argentina Gastritis Treatment Drugs Market
9.5.5.2.1 Argentina Gastritis Treatment Drugs Market by Type
9.5.5.2.2 Argentina Gastritis Treatment Drugs Market by Application
9.5.5.3 Rest of South and Central America Gastritis Treatment Drugs Market
9.5.5.3.1 Rest of South and Central America Gastritis Treatment Drugs Market by Type
9.5.5.3.2 Rest of South and Central America Gastritis Treatment Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GASTRITIS TREATMENT DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GASTRITIS TREATMENT DRUGS MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CIPLA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBOTT LABORATORIES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MICROBIOTIX
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. REDDY'S LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LUPIN LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PERRIGO PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. AstraZeneca
3. Novartis
4. Cipla
5. Abbott Laboratories
6. Microbiotix
7. Reddy's Laboratories
8. Lupin Ltd
9. Perrigo Pharmaceutical
10. Sun Pharmaceutical Industries
TIPRE00021687
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.